Whatever the platform, a transcriptomic study runs through two halves. The first half quantifies expression; the second, and more important, interprets it.
- Quantification. For RNA sequencing this means quality control, alignment or pseudo-alignment, and quantification into an expression matrix of transcripts per sample.
- Differential expression. Statistical testing with DESeq2, edgeR, or limma-voom identifies which genes change between conditions, with multiple-testing correction across thousands of genes.
- Functional enrichment. Gene set and functional enrichment analysis ask whether the changed genes cluster into known biological functions, rather than reading genes one by one.
- Pathway and network analysis. Pathway analysis maps changes onto curated pathways, and co-expression or network analysis finds modules of genes that move together, often pointing to upstream regulators.
The second half is what separates a transcriptomics result from a raw gene list. A coherent enrichment across a known pathway is far more convincing, and far more publishable, than a scattering of isolated significant genes. For the statistical design and modeling underneath this workflow, our data analysis service handles complex designs, covariates, and batch correction.
Transcriptomics is applied across nearly every disease area. In cancer it defines molecular subtypes, biomarkers, and drug-response signatures that pure histology cannot. In immunology and infectious disease it reveals how a host responds to a pathogen or a therapy. In neuroscience it maps the expression changes behind neurodegenerative and psychiatric conditions, and in metabolic and cardiovascular disease it exposes dysregulated pathways. Across all of these the aim is identical: to connect a change in gene expression to a mechanism, a diagnosis, or a treatment.
The same approach extends beyond expression. When the question is about DNA rather than RNA, variants, mutations, and genome structure, genome sequencing analysis is the corresponding workflow, and all of these analyses run under the reproducible approach described on our computational biology service page.
Functional Interpretation: Over-representation, GSEA, and the Background Problem
The step that turns a gene list into biology is enrichment, and the two dominant approaches answer different questions. Over-representation analysis takes a thresholded list of differentially expressed genes and asks, with a hypergeometric or Fisher exact test, whether any annotated category appears more often than chance. Gene set enrichment analysis keeps the whole ranked list and asks, with a Kolmogorov-Smirnov-style running enrichment score, whether the members of a gene set sit systematically near the top or bottom, so it needs no arbitrary cutoff and preserves the direction of change that over-representation analysis throws away. Annotation comes from Gene Ontology, KEGG, Reactome, or the MSigDB hallmark collection, and significance must be corrected for testing many sets at once.
The single most common and most damaging mistake here is the background, or universe. Enrichment is a comparison against a reference set, and the correct reference is the genes that could have been detected and tested in your experiment, not every gene in the genome. Use the whole genome as the background and ubiquitous pathways will look enriched in almost any list, because the comparison is rigged. A second routine problem is redundancy: Gene Ontology terms overlap heavily, so a raw result lists the same signal twenty times. Collapse it with tools such as clusterProfiler simplify or an enrichment-map visualization so that reviewers see distinct programs rather than restatements of one.
